Insider Selling: Oscar Health (NYSE:OSCR) Director Sells $806,000.00 in Stock

Oscar Health, Inc. (NYSE:OSCR) Director Vanessa Wittman sold 25,000 shares of Oscar Health stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $32.24, for a total transaction of $806,000.00. Following the completion of the transaction, the director directly owned 112,121 shares in the company, valued at approximately $3,614,781.04. This trade represents a 18.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oscar Health Stock Down 5.4%

Shares of NYSE:OSCR opened at $28.89 on Friday. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $34.48. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The company has a market cap of $8.92 billion, a PE ratio of 20.63, a price-to-earnings-growth ratio of 0.34 and a beta of 2.37. The firm has a 50 day simple moving average of $30.74 and a 200 day simple moving average of $24.54.

Oscar Health (NYSE:OSCR) last released its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. The company had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The company’s revenue for the quarter was up 70.4% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.89) earnings per share. As a group, research analysts expect that Oscar Health, Inc. will post 1.83 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Raymond James Financial upped their target price on Oscar Health from $34.00 to $42.00 and gave the company an “outperform” rating in a report on Friday, September 18th. Weiss Ratings upgraded shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Piper Sandler reaffirmed an “overweight” rating and set a $48.00 price objective on shares of Oscar Health in a research report on Thursday, September 17th. UBS Group upped their price objective on shares of Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. Finally, Barclays lifted their target price on shares of Oscar Health from $39.00 to $49.00 and gave the company an “overweight” rating in a research note on Thursday, September 17th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Oscar Health currently has an average rating of “Hold” and a consensus price target of $33.90.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the stock. BIT Capital GmbH boosted its stake in Oscar Health by 545.0% during the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after purchasing an additional 5,227,152 shares during the period. Bank of America Corp DE increased its position in Oscar Health by 205.1% in the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock worth $32,808,000 after buying an additional 1,922,732 shares during the period. Wedge Capital Management L L P NC acquired a new position in shares of Oscar Health during the second quarter worth approximately $32,855,000. Dimensional Fund Advisors LP boosted its position in shares of Oscar Health by 22.1% in the first quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company’s stock valued at $48,078,000 after acquiring an additional 759,837 shares during the period. Finally, BNP Paribas Financial Markets boosted its position in shares of Oscar Health by 1,016.9% in the fourth quarter. BNP Paribas Financial Markets now owns 728,920 shares of the company’s stock valued at $10,475,000 after acquiring an additional 663,659 shares during the period. 75.70% of the stock is owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.

Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.